BamSEC and AlphaSense Join Forces
Learn More

ReShape Lifesciences Inc.

NASDAQ: RSLS    
Share price (1/7/25): $4.70    
Market cap (1/7/25): $3.350 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from S-1/A 18 pages Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 42 pages 1,185,000 Shares of Common Stock, 90,000 Pre-Funded Warrants and 1,275,000 Common Warrants of ReShape Lifesciences Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages Shares of Common Stock, Pre-Funded Warrants and Common Warrants of ReShape Lifesciences Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 109 pages Obalon Therapeutics, Inc. 2,015,000 Shares Common Stock ($0.001 Par Value Per Share), Pre-Funded Warrants to Purchase Up to 1,735,000 Shares of Common Stock and Warrants to Purchase Up to 2,812,500 Shares of Common Stock Underwriting Agreement August 1, 2019 Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 68 pages Obalon Therapeutics, Inc. [•] Shares Common Stock ($0.001 Par Value Per Share), Pre-Funded Warrants to Purchase Up to [•] Shares of Common Stock and Warrants to Purchase Up to [•] Shares of Common Stock Underwriting Agreement [ ], 2019 Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 87 pages Obalon Therapeutics, Inc. [•] Shares Common Stock ($0.001 Par Value Per Share) and Pre-Funded Warrants to Purchase Up to [•] Shares of Common Stock Underwriting Agreement [ ], 2019 1 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Obalon Therapeutics, Inc. $10,000,000 Equity Distribution Agreement
12/34/56
EX-1.1
from S-1/A 51 pages Obalon Therapeutics, Inc. [ ● ] Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement
12/34/56